Inflazyme Pharmaceuticals (T.IZP) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Inflazyme Pharmaceuticals (T.IZP)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Joel K. who wrote (1381)	1/19/2000 1:20:00 PM
From: Morag	Read Replies (1) of 1501

Here it is excuse typo's am on lunch so - From today's Globe - page B20 - Market movers section Inflazyme Pharmaceuticals Ltd.s stock is getting a boost after the company made a presentation at a major U.S. health care conference last week. National Bank Financial analyst Cameron Groome says Inflazyme told the Chase H&Q Healthcare Conference in San Francisco that it has identified a new series of potent, orally bioavailable inhibitors of the enzyme phosphodiesterase-4 (PDE4) which don't cause vomiting, a common side effect of treatment for inflammatory bowel disease. Mr. Groome said this is promising for the future of PDE4, which he expects to enter phase 1 clinical trials in 2001. The annual conference provides a forum for biopharmaceutical companies to make presentations to institutional biotech investors. Its "execeptional for a small Canadian company to get invited". Mr Groome told Dow Jones news service. That's it eom

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next